GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Archived. This submission is more than a year old. Votes and new comments are closed, and some of the advice in it may have been superseded — check the community wiki for the current version.
4.9k
c/retatrutide·posted 1 year ago by u/matias_falk

[Lab] 6th independent test on QSC, and the trend is the interesting part

Lab Long Haul ×2 Sourced ×3 Well Actually ×1

Long-ish post, sorry. tl;dr at the bottom.

I have been tracking retatrutide against ApoB for 3 weeks because I could not find anyone who had. The correlation is weaker than I expected, which is itself mildly interesting given how confidently people link the two in here.

Caveats up front: one person, one lab, one assay, no control, and I changed my training in the middle of it, which was stupid.

tl;dr: probably real, definitely smaller than the threads imply, and not worth reorganising your week around.

30,756 up / 25,889 down54% upvoted20 commentsid a1z2g26 Jun 2025

20 comments

7 in this archive, depth 3

best — the order this archive was captured in

u/priya_weiss1.1k points·1 year ago

the glucagon component changes the side effect profile, not just the efficacy

replysharereportpermalink
u/reta_and_regretMOD743 points·1 year ago

This is an urgent-care question wearing a forum question's clothes. Please contact a clinician rather than waiting for replies.

replysharereportpermalink
u/emil_wojcik243 points·1 year ago

TRIUMPH data is phase 2, not phase 3, smaller n and shorter

replysharereportpermalink
u/employer_carveout63 points·1 year ago

research use only, handling and analysis, not protocols

replysharereportpermalink
u/isabela_nilsen285 points·1 year ago

This is correct. Triple agonism is genuinely different.

replysharereportpermalink
u/bilal_osei193 points·1 year ago

triple agonism is phase 2, do not generalise

replysharereportpermalink
u/signe_villalobos444 points·1 year ago

triple agonism plus glucagon is a different physiological state than GIP/GLP-1 dual

replysharereportpermalink
Permalinked branches
Deep branches get their own page so a single reply chain can be linked and read on its own.
About c/retatrutide

Retatrutide: GIP/GLP-1/glucagon triple agonism, the TRIUMPH programme, and the fact that most people discussing it are handling research-grade material with no human-use approval anywhere. Dose-response, heart-rate signal, and the unusually steep phase-2 weight curves get argued about here weekly.

65kmembers
130submissions
Sep 2023created
submissions / month, last year
Sponsored

Sigma-Aldrich Standards

Certified reference materials for peptide identity and purity work.

sigmaaldrich.com
c/retatrutide rules
  1. Retatrutide is not approved anywhere for human use. Posts must not read as usage instructions.
  2. Phase 2 numbers are not maintenance numbers. Cite the trial and the dose arm.
  3. Heart-rate and dose-escalation reports need actual measurements, not impressions.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Moderators
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.